{
  "npi": "1134381320",
  "enumeration_type": "NPI-2",
  "basic": {
    "authorized_official_credential": "M.D.",
    "authorized_official_first_name": "REX",
    "authorized_official_last_name": "ADAMSON",
    "authorized_official_middle_name": "SCOTT",
    "authorized_official_name_prefix": "Dr.",
    "authorized_official_name_suffix": "--",
    "authorized_official_telephone_number": "2095954937",
    "authorized_official_title_or_position": "CEO",
    "enumeration_date": "2008-06-28",
    "last_updated": "2012-08-16",
    "organization_name": "4 N PSYCH, INC.",
    "organizational_subpart": "NO",
    "status": "A"
  },
  "taxonomies": [
    {
      "code": "2084P0800X",
      "desc": "Psychiatry & Neurology, Psychiatry",
      "license": "G85915",
      "primary": true,
      "state": "CA",
      "taxonomy_group": "193200000X - Multi-Specialty Group"
    }
  ],
  "enrichment": {
    "plain_english_specialty": "Board-Certified Psychiatrist (Mental Health & Behavioral Medicine Physician)",
    "certifying_board": "American Board of Psychiatry and Neurology (ABPN)",
    "common_medicare_procedures": [
      "Comprehensive Psychiatric Diagnostic Evaluation (CPT 90792)",
      "Psychopharmacological Management & Supportive Psychotherapy",
      "Medication-Assisted Treatment (MAT) for Substance Use Disorders"
    ],
    "common_part_d_therapeutic_classes": [
      "SSRIs & SNRIs (Sertraline, Escitalopram, Fluoxetine, Duloxetine)",
      "Bupropion, Mirtazapine & Atypical Antipsychotics (Aripiprazole, Quetiapine)",
      "Buprenorphine/Naloxone & Naltrexone (Addiction Recovery)"
    ]
  }
}